Ono K - Search Results

1

Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.

Futamura A, Hieda S, Mori Y, Kasuga K, Sugimoto A, Kasai H, Kuroda T, Yano S, Tsuji M, Ikeuchi T, Irie K, Ono K. Futamura A, et al. Among authors: ono k. J Alzheimers Dis. 2021;80(2):639-646. doi: 10.3233/JAD-201407. J Alzheimers Dis. 2021. PMID: 33579852

2

Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.

Ono K, Noguchi M, Matsumoto Y, Yanase D, Iwasa K, Naiki H, Yamada M. Ono K, et al. Neurobiol Dis. 2005 Nov;20(2):233-40. doi: 10.1016/j.nbd.2005.03.005. Neurobiol Dis. 2005. PMID: 16242632

3

Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.

Ono K, Noguchi-Shinohara M, Samuraki M, Matsumoto Y, Yanase D, Iwasa K, Naiki H, Yamada M. Ono K, et al. Exp Neurol. 2006 Nov;202(1):125-32. doi: 10.1016/j.expneurol.2006.05.019. Epub 2006 Jun 27. Exp Neurol. 2006. PMID: 16806179

4

Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.

Ono K, Noguchi-Shinohara M, Yoshita M, Naiki H, Yamada M. Ono K, et al. Exp Neurol. 2007 Feb;203(2):579-83. doi: 10.1016/j.expneurol.2006.08.012. Epub 2006 Oct 2. Exp Neurol. 2007. PMID: 17011551

5

The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.

Ono K, Naiki H, Yamada M. Ono K, et al. Curr Pharm Des. 2006;12(33):4357-75. doi: 10.2174/138161206778793010. Curr Pharm Des. 2006. PMID: 17105432 Review.

6

Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.

Matsumoto Y, Yanase D, Noguchi-Shinohara M, Ono K, Yoshita M, Yamada M. Matsumoto Y, et al. Among authors: ono k. Dement Geriatr Cogn Disord. 2007;23(4):241-5. doi: 10.1159/000100019. Epub 2007 Feb 19. Dement Geriatr Cogn Disord. 2007. PMID: 17310121 Free article.

7

CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.

Noguchi-Shinohara M, Tokuda T, Yoshita M, Kasai T, Ono K, Nakagawa M, El-Agnaf OM, Yamada M. Noguchi-Shinohara M, et al. Among authors: ono k. Brain Res. 2009 Jan 28;1251:1-6. doi: 10.1016/j.brainres.2008.11.055. Epub 2008 Nov 28. Brain Res. 2009. PMID: 19071095

8

REVIEW: Curcumin and Alzheimer's disease.

Hamaguchi T, Ono K, Yamada M. Hamaguchi T, et al. Among authors: ono k. CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x. CNS Neurosci Ther. 2010. PMID: 20406252 Free PMC article. Review.

9

Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.

Ikeda T, Ono K, Elashoff D, Condron MM, Noguchi-Shinohara M, Yoshita M, Teplow DB, Yamada M. Ikeda T, et al. Among authors: ono k. J Alzheimers Dis. 2010;21(1):81-6. doi: 10.3233/JAD-2010-100075. J Alzheimers Dis. 2010. PMID: 20413863

10

A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.

Morinaga A, Ono K, Ikeda T, Ikeda Y, Shima K, Noguchi-Shinohara M, Samuraki M, Yanase D, Yoshita M, Iwasa K, Mastunari I, Yamada M. Morinaga A, et al. Among authors: ono k. Dement Geriatr Cogn Disord. 2010;30(4):285-92. doi: 10.1159/000320265. Epub 2010 Sep 22. Dement Geriatr Cogn Disord. 2010. PMID: 20861634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,638 results

Search Page